Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ERIC 2018 | Complete epigenome of CLL reveals important areas of dysregulation

Iñaki Martín-Subero • 25 Oct 2018
ERIC 2018
Chronic Lymphocytic Leukemia Leukemia

Work showing the complete epigenome of chronic lymphocytic leukemia (CLL) for the first time was released this year, revealing the extent and impact of epigenetic changes involved. We spoke to Iñaki Martín-Subero, PhD, of the Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain, about the results of this interesting analysis. This Interview took place at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.

More from Iñaki Martín-Subero

2:40
Chromatin activation underlying pathogenic mechanisms in MM & CLL
Iñaki Martín-Subero • 22 Sep 2019
2:16
Tertiary structure, chromatin modifications and nuclear organisation in CLL
Iñaki Martín-Subero • 22 Sep 2019
1:38
Therapeutically targeting transcription factors in CLL
Iñaki Martín-Subero • 25 Oct 2018
1:35
Shifting the focus in CLL: the epigenome
Iñaki Martín-Subero • 25 Oct 2018

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals